LILETTA IUD May Offer Cost Savings to 340B Covered Entities

AAFCPAs would like to make healthcare clients aware of a potential cost savings on an Inter-Uterine Device (IUD) for eligible patients.  Medicines360 has received FDA approval for an IUD, named LILETTA®.  Medicines360 is a nonprofit pharmaceutical company, and as part of their mission, they are making LILETTA® available at a reduced, fixed price of $50.00 to clinics enrolled in the 340B Drug Pricing program.  Medicines360 has reported that this price will never increase.  Many 340B covered entities are currently paying $500 – $2,000 per device, so LILETTA may offer a significant cost savings.
340B covered entities may visit the LILETTA website for more information on procurement, billing and benefits.  AAFCPAs encourage clients to analyze which patients might qualify, and assess the benefit and cost savings this product may provide to the 340B covered entity and its patients.  We also encourage you to fully understand reimbursement rates and how billing procedures for the LILETTA would affect your current processes.
More information is available at or by calling 855.545.3882.
AAFCPAs delivers a full range of solutions solving the challenges that AAF’s healthcare clients face, including: guidance on compliance with 340B pharmacy program requirements, and program audits of both on-site and contract pharmacies.  If you have any questions or need additional information, please contact your AAF Partner, or Courtney McFarland, CPA: 774.512.4051,

About the Author

Courtney McFarland
Courtney is an audit partner in the firm’s Healthcare Practice with over 15 years of assurance experience and a comprehensive understanding of the nuances of the healthcare industry. She delivers a full range of solutions solving the challenges that AAFCPAs’ healthcare clients face, including: audits in accordance with Uniform Guidance/Single Audit and Government Auditing Standards, 340B pharmacy program requirements, best practices for reconciliation & analysis of statistical and programmatic data, tracking and monitoring risk-based contracts, maximizing reimbursements, and guidance on healthcare reform. Courtney is a member of AAFCPAs’ Revenue Recognition Task Force, dedicated to helping the firm and clients understand best practices for an efficient and effective implementation of the robust new framework.

Leave a Reply